Podorbit
DiscoverPodcastsGuestsCompanies
Podorbit

Tech podcasts · indexed by guest & company

PrivacyTermsSupport
support@podorbit.app
Chan Zuckerberg Biohub

Chan Zuckerberg Biohub

czbiohub.org →

People from Chan Zuckerberg Biohub

Mark Zuckerberg

Co-Founder

Priscilla Chan

Co-Founder

Alex Rives

Head of Science

Sal Candido

Unknown role

Episodes featuring Chan Zuckerberg Biohub (29)

"The Cognitive Revolution" | AI Builders, Researchers, and Live Player Analysis/Oct 20, 2026/1h 5m

A World Model of Life: Biohub's Alex Rives on Virtual Cells, Measurement, & the $1.8B Data Push

Alex Rives, Head of Science at Biohub and former lead of the ESM protein language model project, joins Nathan to discuss Biohub's mission to construct a predictive world model of life. Supported by an expanded $1.8 billion Virtual Biology Initiative alongside partners including the Department of Energy, NIH, Google DeepMind, and Meta, Rives outlines the massive push to map contextual cellular biology across hundreds of billions of cells. He breaks down why today's AI architectures fall short of simulating true virtual cells, emphasizing the need for breakthrough measurement technologies like the laser phase plate to observe biology at multi-scale resolution. The conversation examines the path toward achieving an information-level cell model within five years to ultimately transition medicine from traditional drugs to programmable interventions against cancer and degenerative disease. For full show notes, links, and references, read the episode page: https://www.cognitiverevolution.ai/a-world-model-of-life-biohub-s-alex-rives-on-virtual-cells-measurement-the-1-8b-data-push/ Sponsors: Parallel: Parallel provides enterprise-grade web search APIs for AI agents, offering the optimal balance of quality, speed, and cost. Get started for free at https://parallel.ai/tcr OutSystems: OutSystems is the leading agentic systems platform that enables enterprises to engineer, orchestrate, and govern AI applications on a single unified platform. Learn more and see how it works at https://outsystems.com/tcr Tasklet: Tasklet empowers your business with AI agents that connect to your tools and automate recurring workflows with no code required. Visit https://tasklet.ai and use code cog rev for $50 in free credits CHAPTERS: (00:00) About the Episode (03:58) Biohub's grand mission (09:18) Limitations of virtual cells (13:37) World models of biology (19:35) The $1.8B data initiative (Part 1) (19:40) Sponsors: Parallel | OutSystems (22:58) The $1.8B data initiative (Part 2) (29:29) Bridging multiscale biological systems (35:44) Learning across model organisms (Part 1) (35:49) Sponsor: Tasklet (37:26) Learning across model organisms (Part 2) (42:24) Pretraining and empirical AI (52:04) Unifying biology and language (56:32) Continuous monitoring and health (59:30) Episode Outro (01:03:11) Outro PRODUCED BY: https://aipodcast.ing SOCIAL LINKS: Website: https://www.cognitiverevolution.ai Twitter (Podcast): https://x.com/cogrev_podcast Twitter (Nathan): https://x.com/labenz LinkedIn: https://linkedin.com/in/nathanlabenz/ Youtube: https://youtube.com/@CognitiveRevolutionPodcast Apple: https://podcasts.apple.com/de/podcast/the-cognitive-revolution-ai-builders-researchers-and/id1669813431 Spotify: https://open.spotify.com/show/6yHyok3M3BjqzR0VB5MSyk

Alex Rives

Head of Science

Chan Zuckerberg BiohubChan Zuckerberg Biohub
Latent Space: The AI Engineer Podcast/Oct 10, 2026/32m

🔬 Why AlphaFold Didn't Solve Protein Folding — Pushmeet Kohli, Google DeepMind & Sal Candido, Biohub

<p>From the Bitter Lesson of AI scaling to the unsolved mysteries of protein folding, Google DeepMind’s Pushmeet Kohli and Biohub’s Sal Candido are rethinking what it takes to build AI that truly understands biology. In this special panel moderated by Bra...</p><p><a href="https://www.latent.space/p/biohub-deepmind">Full show notes and links</a></p>

Pushmeet Kohli

VP of Science and Strategic Initiatives

Google DeepMindGoogle DeepMindDeepMindDeepMind
Sal Candido
Chan Zuckerberg BiohubChan Zuckerberg Biohub
The a16z Show/Jul 9, 2026/45m

Mark Zuckerberg & Priscilla Chan: How AI Will Help Cure Disease

As part of our summer replay series, we're revisiting one of our favorite conversations from the past year. Mark Zuckerberg and Dr. Priscilla Chan join Ben Horowitz, Vineeta Agarwala, and Erik Torenberg to discuss the Chan Zuckerberg Initiative's ambitious effort to help cure, prevent, and manage disease by the end of the century. Rather than funding individual breakthroughs, CZI is focused on building the tools and infrastructure that can accelerate scientific discovery across entire fields. The conversation explores Biohub, Cell Atlas, virtual cell models, open biological datasets, and the growing role of AI in helping researchers better understand human biology. They discuss why biology still lacks a "periodic table of elements," how AI could help scientists test hypotheses before running expensive experiments, and why pairing frontier biology with frontier AI may unlock a new era of medical discovery.   Resources: Follow Mark Zuckerberg on X: https://x.com/finkd Follow Dr. Priscilla Chan on Instagram: https://www.instagram.com/priscillachan Follow Ben Horowitz on X: https://x.com/bhorowitz Follow Vineeta Agarwala on X: https://x.com/vintweeta Stay Updated: Find a16z on YouTube: YouTube Find a16z on X Find a16z on LinkedIn Listen to the a16z Show on Spotify Listen to the a16z Show on Apple Podcasts Follow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Priscilla Chan

Co-CEO

Chan Zuckerberg InitiativeChan Zuckerberg InitiativeChan Zuckerberg BiohubChan Zuckerberg Biohub
No Priors: Artificial Intelligence | Technology | Startups/Jun 10, 2026/56m

Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives

Biohub started with an ambitious goal of curing, preventing, and managing all disease by the end of the century. A decade later, thanks to the convergence of frontier AI and biological data, that goal may have been too conservative. In this episode, Elad Gil and Sarah Guo sit down with Biohub co-founders Mark Zuckerberg and Priscilla Chan, alongside Biohub Head of Science Alex Rives. Together, they discuss Biohub’s $500 million virtual biology initiative, which integrates frontier AI with wet-lab work to build predictive world models of cells, proteins, and systems. They also talk about their newly announced open-source engine for digital protein and antibody design, ESMFold2; why Biohub is a nonprofit rather than a venture-backed startup; and how hierarchical simulations will soon allow doctors to treat patients at an individual, mechanistic level.   Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @Biohub | @finkd | @alexrives | @ChanZuckerberg Chapters: 00:00 – Cold Open 01:02 - Mark Zuckerberg, Priscilla Chan, and Alex Rives Introduction 01:26 – Why Biohub and Their Mission 08:27 – Integrating Frontier AI and Frontier Biology 09:45 – Micro to Macro Biological Modeling 14:22 – Mechanistic Interpretiability  16:58 – Why Biohub is a Non-Profit 21:41 – Understanding How Biology Works 24:23 – Timeline for Curing All Diseases 26:25 – Translating Research to Patient Impact 28:04 – Launch of ESMFold2 32:13 – Tackling Off-Target Effects and Edge Cases 38:39 – Putting the Tech in Individual Hands 41:06 – Talent at Biohub 44:25 – What’s Next After ESMFold2 46:10 –  Connecting ESMFold2 to Agentic Systems 46:51 – The Virtual Cell 49:33 – Defining Success for Biohub 51:52 – Biohub Strategy Update 56:20 – Conclusion

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Priscilla Chan

Co-CEO

Chan Zuckerberg InitiativeChan Zuckerberg InitiativeChan Zuckerberg BiohubChan Zuckerberg Biohub
Alex Rives

Head of Science

Chan Zuckerberg BiohubChan Zuckerberg Biohub
Latent Space: The AI Engineer Podcast/May 27, 2026/1h 10m

🔬ESM: The Bitter Lesson is Coming for Proteins - Alex Rives, BioHub

Editor’s note: In our first BioHub pod with Priscilla and Mark they discussed their acquisition of EvoScale, led by Alex Rives, who is now Head of Science at BioHub. With ESM-1 they trained language models on millions of protein sequences drawn from across life, with a simple “next token” objective: predict the amino acids that have been randomly masked out, based on the context of the rest of the sequence. But they soon found that these models also learned biological structure and function, including properties the model had never been explicitly shown AND that this ability scales predictably with compute, leading to ESM2 and ESM3. Today, Alex announced ESMFold 2, an open scientific engine to power prediction, design, and discovery across protein biology. Building on Cryo-EM data (discussed in the CZI pod), ESMFold2 reports state of the art performance on protein interactions, especially antibodies, a critical modality for therapeutics, and evidence that inference time scaling is also working across five targets in cancer and immunology. In a nod to that other famous AI x protein folding project, they are also releasing an atlas of 6.8 billion proteins, and 1.1 billion predicted structures, which you can play around with on their website. We are honored to work with them for this huge release! One of the refrains we’ve heard on the Science pod has been that protein folding, materials design, cellular biology, etc. are very different problems from Language Modeling. They definitely are. Yet Alex Rives and the ESM team at BioHub just released a preprint and model, demonstrating that vanilla BERT-like transformer models trained on sufficiently large and diverse data sets can beat specialized models like AlphaFold3 on some of the hardest protein-related problems. Andrew White had a great segment in our first LS-Science episode that explained how mind blowing AlphaFold2 was when it was released in 2020: it suddenly solved problems on a GPU on your desktop that DESRes had built custom-ASIC supercomputer clusters to solve. John Jumper and Demmis Hassabis received the Nobel Prize in Chemistry for this work. AlphaFold2 took advantage of an very clever observation: if multiple species co-evolve pairs of mutations, this implies that the mutations correspond to parts of the protein that are close in 3d space. This is usually shorthanded as MSAs (multi-sequence alignments), and is the key insight which makes AlphaFold2 so effective. Like other inductive biases, however, it hurts generalization. Scale-pilled before it was cool If you take a look at the timeline for scaling laws for LLMs and release of structure prediction models, the ESM team notably doubled down on their MSAs-be-damned approach after AlphaFold2 released. This obviously requires a great deal of belief in the scale hypothesis. Why the conviction? ESM developed at a time when many of the scaling laws and the “Bitter Lesson” were proving increasingly correct. AlphaFold2’s wild success must have been both exciting and bitterly disappointing. But using MSAs mean that the model is is dependent on training data that contains MSAs in order to be accurate in a given domain. For things like antibodies that don’t have MSAs to train on, AlphaFold tends to do poorly. ESM takes a different approach: learn the relationship between different proteins by unsupervised training on as much diversity as you can find (sound familiar?) and then correlate that back to structures know from the Protein Data Bank (PDB) and other sources. In other words, a World Model. World Model for proteins “World Model” is a hype term that I define like this: Use unsupervised training to learn abstract patterns from the data: * The abstraction should be semantic - novel constructions represent things that obey the rules of the real world * The abstraction should be compositional - recombining different patterns leads to novel and often valid constructions * The abstraction should support generalization - it predicts things in the real world it wasn’t trained on Once you have a world model, you can attach “heads” to it for downstream tasks: predict properties of a protein, decompose its functional features, or search the representation for proteins that meet design criteria. The two big models BioHub just released under MIT license map directly onto this: * World model → ESMC (a model trained on 2.8 billion sequences) * Structure-prediction head → ESMFold2 One of the interesting ways the world model can “predict things” is to generate proteins sequences and then measure the predicted properties, such as binding affinity, in the lab. Alex talks in the episode about validating some of the harder molecules they predicted in the wet-lab. Very cool! Another way is to use mech-interp techniques such as Sparse Auto Encoders (SAEs) to extract semantic features from your model, and then find novel features that predict unknown biology. I won’t spoil this part for you: it was one of the highlights of the episode for me! A cell is a computer We have all heard that genes are like computer programs, but usually the analogy fizzles after that. Of course genes are transcribed into RNA and RNA is translated into proteins, so genes are programs for building proteins, but that carries the analogy only to “binary digits are programs.” Here’s a better analogy: you can think of the cell nucleus as a storage device / storage controller, the ribosome as a JIT-compiler and runtime, and the semantic features that we learn from our world model via SAEs as functions, proteins as processes that interact together in workflows (signalling pathways) to produce behaviors and outputs (phenotypes). Like functions, the SAE features have a hierarchical composition from local, secondary and tertiary structures (mimicing protein structure), but also motifs that are conceptual, such as membrane integrations, disordered regions and disulfide bonds. As we learn to compose these features we into novel protein designs, we move further towards programmable biology. Alex goes into much more detail about this in the episode, as well as: * Principles for new data collection * BioHub’s vision * Modeling the cell Enjoy! Full Video podcast please like and subscribe! * X: https://x.com/alexrives * LinkedIn: This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.latent.space/subscribe

Alex Rives

Head of Science

Chan Zuckerberg BiohubChan Zuckerberg Biohub
"The Cognitive Revolution" | AI Builders, Researchers, and Live Player Analysis/Feb 1, 2026/1h 2m

The AI-Powered Biohub: Why Mark Zuckerberg & Priscilla Chan are Investing in Data, from Latent.Space

This crossover episode from the Latent Space podcast features Mark Zuckerberg and Priscilla Chan on the 10-year anniversary of the Chan Zuckerberg Initiative and their expanded Biohub vision. They discuss how a “Frontier Biology Lab” working in sync with a “Frontier AI Lab” could enable breakthroughs like a Virtual Cell and true N-of-1 precision medicine. The conversation covers the acquisition of Evolutionary Scale and ESM3, new biological data collection at scale, and how AI-powered biology might transform drug discovery and disease prevention. Sponsors: Blitzy: Blitzy is the autonomous code generation platform that ingests millions of lines of code to accelerate enterprise software development by up to 5x with premium, spec-driven output. Schedule a strategy session with their AI solutions consultants at https://blitzy.com Framer: Framer is an enterprise-grade website builder that lets business teams design, launch, and optimize their.com with AI-powered wireframing, real-time collaboration, and built-in analytics. Start building for free and get 30% off a Framer Pro annual plan at https://framer.com/cognitive Serval: Serval uses AI-powered automations to cut IT help desk tickets by more than 50%, freeing your team from repetitive tasks like password resets and onboarding. Book your free pilot and guarantee 50% help desk automation by week four at https://serval.com/cognitive Tasklet: Tasklet is an AI agent that automates your work 24/7; just describe what you want in plain English and it gets the job done. Try it for free and use code COGREV for 50% off your first month at https://tasklet.ai Claude Claude is the AI collaborator that understands your entire workflow, from drafting and research to coding and complex problem-solving. Start tackling bigger problems with Claude and unlock Claude Pro’s full capabilities at ⁠⁠https://claude.ai/tcr⁠ CHAPTERS: (00:00) About the Episode (04:27) CZI origins and focus (08:29) Why tools over cures (14:43) Virtual cells and imaging (Part 1) (20:19) Sponsors: Blitzy | Framer (23:24) Virtual cells and imaging (Part 2) (25:22) Data diversity and grounding (32:30) Evaluating models and Biohub (Part 1) (37:53) Sponsors: Serval | Tasklet (40:42) Evaluating models and Biohub (Part 2) (41:06) Future healthcare and aging (53:39) Modeling scales and immunity (58:53) Timelines, data, and collaboration (01:04:01) Outro PRODUCED BY: https://aipodcast.ing SOCIAL LINKS: Website: https://www.cognitiverevolution.ai Twitter (Podcast): https://x.com/cogrev_podcast Twitter (Nathan): https://x.com/labenz LinkedIn: https://linkedin.com/in/nathanlabenz/ Youtube: https://youtube.com/@CognitiveRevolutionPodcast Apple: https://podcasts.apple.com/de/podcast/the-cognitive-revolution-ai-builders-researchers-and/id1669813431 Spotify: https://open.spotify.com/show/6yHyok3M3BjqzR0VB5MSyk

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Priscilla Chan

Co-CEO

Chan Zuckerberg InitiativeChan Zuckerberg InitiativeChan Zuckerberg BiohubChan Zuckerberg Biohub
The a16z Show/Nov 6, 2025/45m

Mark Zuckerberg & Priscilla Chan: How AI Will Cure All Disease

Priscilla Chan and Mark Zuckerberg join a16z’s Ben Horowitz, Erik Torenberg, and Vineeta Agarwala to share how the Chan Zuckerberg Initiative is building the computational tools that will accelerate the cure, prevention, and management of all disease by century's end. They explain why basic science needs $100 million-scale projects that traditional NIH grants can't fund, how their Cell Atlas became biology's missing periodic table with millions of cells catalogued in open-source format, and why their new virtual cell models will let scientists test high-risk hypotheses in silico before investing in expensive wet lab work. Plus: the organizational shift unifying the Biohub under AI leadership, what happens when biologists and engineers sit side-by-side, and why modern biology labs are expanding compute instead of square footage.   Timestamps: 4:17 - Building tools to accelerate scientific discovery 5:47 - The credible path to funding basic science 7:21 - Biohub = Frontier Biology + Frontier AI 9:05 - Challenges building on a 10-15 year timeline 9:43 - How CZI chooses what to work on 11:15 - Making sense of science with LLMs 11:31 - Measuring success in the therapeutic realm 13:32 - “Most diseases should be thought of as rare diseases” 15:39 - Inspiration: building a periodic table for biology 19:27 - Why virtual cells? 21:17 - The Biohub Master Plan 21:51 - How virtual cell models allow more risk taking 28:15 - Bringing CZI & Biohub together 30:32 - Why Biohub matters 33:36 - The importance of interface design in democratizing scientific discovery 35:34 - How Biohub encourages cross-functional collaboration 40:38 - Looking ahead: the broader impact of AI on biotech   Stay Updated:  If you enjoyed this episode, be sure to like, subscribe, and share with your friends! Find a16z on X: https://x.com/a16z Find a16z on LinkedIn: https://www.linkedin.com/company/a16z Listen to the a16z Podcast on Spotify: https://open.spotify.com/show/5bC65RDvs3oxnLyqqvkUYX Listen to the a16z Podcast on Apple Podcasts: https://podcasts.apple.com/us/podcast/a16z-podcast/id842818711 Follow our host: https://x.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Stay Updated: Find a16z on YouTube: YouTube Find a16z on X Find a16z on LinkedIn Listen to the a16z Show on Spotify Listen to the a16z Show on Apple Podcasts Follow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Priscilla Chan

Co-CEO

Chan Zuckerberg InitiativeChan Zuckerberg InitiativeChan Zuckerberg BiohubChan Zuckerberg Biohub
Pivot/Oct 14, 2025/1h 21m

Mark Zuckerberg on the AI bubble and Meta's new display glasses | ACCESS

Pivot is off for the holiday! Kara and Scott will return on Friday, but in the meantime, we're bringing you the premiere episode of ACCESS. Tech insiders Alex Heath and Ellis Hamburger talk all things Mark Zuckerberg, from the newest Meta Ray-Ban Display glasses to the beverage selections in the new Meta AI Lab. Alex then sits down with Zuck himself ahead of the 2025 Meta Connect conference. Find ACCESS on YouTube or your favorite podcast app. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Dwarkesh Podcast/Apr 29, 2025/1h 15m

Mark Zuckerberg — AI will write most Meta code in 18 months

Zuck on: * Llama 4, benchmark gaming * Intelligence explosion, business models for AGI * DeepSeek/China, export controls, & Trump * Orion glasses, AI relationships, and preventing reward-hacking from our tech. Watch on Youtube; listen on Apple Podcasts and Spotify. ---------- SPONSORS * Scale is building the infrastructure for safer, smarter AI. Scale’s Data Foundry gives major AI labs access to high-quality data to fuel post-training, while their public leaderboards help assess model capabilities. They also just released Scale Evaluation, a new tool that diagnoses model limitations. If you’re an AI researcher or engineer, learn how Scale can help you push the frontier at scale.com/dwarkesh. * WorkOS Radar protects your product against bots, fraud, and abuse. Radar uses 80+ signals to identify and block common threats and harmful behavior. Join companies like Cursor, Perplexity, and OpenAI that have eliminated costly free-tier abuse by visiting workos.com/radar. * Lambda is THE cloud for AI developers, with over 50,000 NVIDIA GPUs ready to go for startups, enterprises, and hyperscalers. By focusing exclusively on AI, Lambda provides cost-effective compute supported by true experts, including a serverless API serving top open-source models like Llama 4 or DeepSeek V3-0324 without rate limits, and available for a free trial at lambda.ai/dwarkesh. To sponsor a future episode, visit dwarkesh.com/p/advertise. ---------- TIMESTAMPS (00:00:00) – How Llama 4 compares to other models (00:11:34) – Intelligence explosion (00:26:36) – AI friends, therapists & girlfriends (00:35:10) – DeepSeek & China (00:39:49) – Open source AI (00:54:15) – Monetizing AGI (00:58:32) – The role of a CEO (01:02:04) – Is big tech aligning with Trump? (01:07:10) – 100x productivity Get full access to Dwarkesh Podcast at www.dwarkesh.com/subscribe

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Acquired/Sep 30, 2024/2h 25m

Acquired LIVE from Chase Center (with Daniel Ek, Emily Chang, Jensen Huang and Mark Zuckerberg)

Here it is: the complete video of the most unbelievable night of Acquired’s nine-year life… our sold out live show at the Chase Center in San Francisco. We joked during the months (months!) of preparation leading up to this event that it was like planning a wedding for 6,000 Acquired fans, and the guest list included Jamie Dimon, Daniel Ek, Emily Chang, Jensen Huang and Mark Zuckerberg… no pressure! But thanks to our amazing partnership with J.P. Morgan Payments, together we were able to make something incredible. Tune in and enjoy the celebration! Sponsors: Anthropic: https://bit.ly/acquiredclaude25 Sentry: https://bit.ly/acquiredsentry WorkOS: https://acquired.fm/unpluggedPlaying Cards: https://bit.ly/workOSshop (Code: ACQDECK) Statsig: https://bit.ly/acquiredstatsig26 Links: Mike Taylor, the truly incomparable performer of Who Got the Truth? Mike Amiri (who designed Mark’s shirt) More Acquired! Get email updates with hints on next episode and follow-ups from recent episodes Join the Slack Subscribe to ACQ2 Merch Store! © Copyright 2015-2026 ACQ, LLC Photo Credit: Mark Zuckerberg by Jeff Sainlar / Meta © Copyright 2024 ACQ, LLC ‍Note: Acquired hosts and guests may hold assets discussed in this episode. This podcast is not investment advice, and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any financial transactions.

Daniel Ek
Daniel Ek

CEO and Co-Founder

SpotifySpotify
Jensen Huang
Jensen Huang

Co-founder & CEO, NVIDIA

NVIDIANVIDIA
Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Decoder with Nilay Patel/Sep 25, 2024/1h 7m

Why Mark Zuckerberg wants to end the smartphone era

We have a very special episode of Decoder today. It’s become a tradition every fall to have Verge deputy editor Alex Heath interview Meta CEO Mark Zuckerberg on the show at Meta Connect. This year, before his interview with Mark, Alex got to try a new pair of experimental AR glasses the company is calling Orion.  Alex talked to Mark about a whole lot more, including why the company is investing so heavily in AR, why he's shifted away from politics, Mark's thoughts on the link between teen mental health and social media, and why the Meta chief executive is done apologizing for corporate scandals like Cambridge Analytica that he feels were overblown and misrepresented.   Links: Hands-on with Orion, Meta’s first pair of AR glasses | The Verge The biggest news from Meta Connect 2024 | The Verge Mark Zuckerberg: publishers ‘overestimate the value’ of their work for training AI | The Verge Meta extends its Ray-Ban smart glasses deal beyond 2030 | The Verge The Ray-Ban Meta smart glasses actually make the future look cool | The Verge Meta has a major opportunity to win the AI hardware race | The Verge Instagram is putting every teen into more private and restrictive new account | The Verge Threads isn’t for news and politics, says Instagram’s boss | The Verge Facebook puts news on the back burner | The Verge Meta is losing a billion dollars on VR and AR every single month | The Verge Transcript: https://www.theverge.com/e/24017522 Credits:  Decoder is a production of The Verge and is part of the Vox Media Podcast Network. Our producers are Kate Cox and Nick Statt; our editor is Callie Wright. This episode was additionally produced by Brett Putman and Vjeran Pavic. Our supervising producer is Liam James.  The Decoder music is by Breakmaster Cylinder.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub
Acquired/Sep 18, 2024/1h 29m

The Mark Zuckerberg Interview

Mark is the iconic founder CEO of our time. At Chase Center on September 10, 2024, he did an unprecedented thing: a live conversation in front of 6,000 people on Meta’s company strategy, sharing stories from early Facebook history, and his thoughts on the future of AI, VR, and AR. Mark was remarkably candid in our discussion, and gave us a window into his real and intense daily demeanor leading Meta. (And his other life endeavors!) We can't wait to release the complete video of the whole night, including our surprise conversations with Daniel Ek, Emily Chang, and cameo appearances from Jensen Huang and Mike Taylor (the incredible singer of “Who Got the Truth?”). That’s coming in a couple weeks, but for now: enjoy this conversation with Mark Zuckerberg. Sponsors: Anthropic: https://bit.ly/acquiredclaude25 Sentry: https://bit.ly/acquiredsentry WorkOS: https://acquired.fm/unpluggedPlaying Cards: https://bit.ly/workOSshop (Code: ACQDECK) Statsig: https://bit.ly/acquiredstatsig26 Links: Mike Amiri (who designed Mark’s shirt!) More Acquired! Get email updates with hints on next episode and follow-ups from recent episodes Join the Slack Subscribe to ACQ2 Merch Store! © Copyright 2015-2026 ACQ, LLC Photo Credit: Mark Zuckerberg by Jeff Sainlar / Meta © Copyright 2024 ACQ, LLC ‍Note: Acquired hosts and guests may hold assets discussed in this episode. This podcast is not investment advice, and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any financial transactions.

Mark Zuckerberg

Co-founder and CEO

MetaMetaChan Zuckerberg InitiativeChan Zuckerberg InitiativeFacebookFacebookChan Zuckerberg BiohubChan Zuckerberg Biohub

Sign in to see 17 more episodes

Free, one click with Google. Browse every guest and company across the catalog.